Aviva
ALKS icon

Aviva’s Alkermes ALKS Stock Holding History

Aviva’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,354
Closed -$543K – 859
2026
Q1 		$543K Sell
15,354
-1,592
-9% -$49.4K ﹤0.01% 679
2025
Q4 		$474K Sell
16,946
-199
-1% -$5.96K ﹤0.01% 804
2025
Q3 		$514K Sell
17,145
-2,349
-12% -$66.2K ﹤0.01% 726
2025
Q2 		$558K Buy
19,494
+2,069
+12% +$61.6K ﹤0.01% 688
2025
Q1 		$575K Sell
17,425
-3,489
-17% -$114K ﹤0.01% 747
2024
Q4 		$601K Sell
20,914
-2,280
-10% -$65.5K ﹤0.01% 700
2024
Q3 		$649K Sell
23,194
-2,422
-9% -$64.6K ﹤0.01% 752
2024
Q2 		$617K Buy
25,616
+3,548
+16% +$87K ﹤0.01% 752
2024
Q1 		$597K Buy
+22,068
New +$627K ﹤0.01% 844
2019
Q3 		– Sell
-57,045
Closed -$1.29M – 796
2019
Q2 		$1.29M Sell
57,045
-1,429
-2% -$39.2K 0.01% 721
2019
Q1 		$2.13M Buy
58,474
+1,001
+2% +$33.1K 0.01% 643
2018
Q4 		$1.7M Sell
57,473
-16,519
-22% -$609K 0.01% 654
2018
Q3 		$3.14M Sell
73,992
-2,679
-3% -$116K 0.02% 626
2018
Q2 		$3.16M Sell
76,671
-1,132
-1% -$51.6K 0.02% 621
2018
Q1 		$4.51M Sell
77,803
-7,030
-8% -$411K 0.03% 553
2017
Q4 		$4.64M Sell
84,833
-7,146
-8% -$365K 0.03% 570
2017
Q3 		$4.68M Buy
91,979
+3,820
+4% +$204K 0.03% 584
2017
Q2 		$5.11M Buy
88,159
+4,525
+5% +$263K 0.03% 566
2017
Q1 		$4.89M Sell
83,634
-4,081
-5% -$231K 0.03% 584
2016
Q4 		$4.88M Buy
87,715
+5,300
+6% +$283K 0.03% 577
2016
Q3 		$3.88M Buy
82,415
+3,014
+4% +$143K 0.02% 612
2016
Q2 		$3.43M Buy
79,401
+12,676
+19% +$523K 0.02% 600
2016
Q1 		$2.28M Buy
66,725
+365
+0.6% +$14.4K 0.02% 672
2015
Q4 		$5.27M Sell
66,360
-20
-0% -$1.4K 0.04% 471
2015
Q3 		$3.9M Buy
+66,380
New +$4.38M 0.03% 561

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Aviva's ALKS Position: Q2 2026 in Review

Aviva sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 15,354 shares — an estimated $543K sold.

Aviva first reported a position in ALKS in Q3 2015 and held it in 25 quarters. The position peaked at $5.27M in Q4 2015. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Aviva reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
  • Aviva sold 15,354 Alkermes shares in Q2 2026, an estimated $543K.
  • Aviva first reported a position in Alkermes in Q3 2015 and held it in 25 quarters.
  • Aviva's Alkermes position peaked at $5.27M in Q4 2015.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.